Top prospects in this year’s National Football League draft stopped by Kravis Children’s Hospital at Mount Sinai on Thursday, May 8, the first day of the draft. They delighted pediatric patients with smiles, NFL goody bags, and visits to their rooms and to The Zone, a therapeutic and educational play area.
Specific cellular pathways, along which genetic mutations occur, appear to play a key role in the development of autism spectrum disorders (ASD), according to new research from Icahn School of Medicine at Mount Sinai.
The findings, published online in the April 24, 2014, issue of The American Journal of Human Genetics, provide scientists with a better understanding of the complex genetic architecture involved in ASD, which has its roots in early brain development.
The Icahn School of Medicine at Mount Sinai is launching a unique Master’s program specifically geared to give health care leaders new knowledge and skills as they confront the challenges of delivering patient care in an era of unprecedented reform. The Master’s Program in Health Care Delivery Leadership is offered through the Department of Population Science and Policy and is currently accepting applications for its inaugural cohort that begins this fall.
When colleagues nominated Joshua Lasseigne, BSN, RN, CHPN, a hospice and palliative care nurse at The Mount Sinai Hospital for a clinical excellence award, they summarized his exceptional skills in a nomination letter. “He truly helps patients and families through the darkest hours of their lives with a soft voice of hope and strong loving hugs,” they wrote. “He has a passion for nursing, a sense of optimism, and is an excellent role model and mentor.”
Mount Sinai leaders saluted the more than 1,200 volunteers who support The Mount Sinai Hospital and Icahn School of Medicine at Mount Sinai during a recent breakfast held to honor their commitment and dedication.
Following a performance by two volunteer flutists from the Music for Healing program, Peter W. May, Chairman, Boards of Trustees, Mount Sinai Health System, told guests: “There is a broad range of individuals who help Mount Sinai. While some have the capability to support us financially, many more give their valued time, spirit, and compassion to help patients, families, and staff. We salute your enthusiasm and accomplishments.”
Ketamine, a drug approved for use as a general anesthetic and sedative, also appears to provide significant relief to patients with major depressive disorder, and those with chronic post-traumatic stress disorder (PTSD), according to two separate studies conducted by researchers at Icahn School of Medicine at Mount Sinai.
After launching a much-publicized campaign in October to promote the influenza vaccination for faculty, staff, and students, the Mount Sinai Health System will report a record rate of vaccination compliance to the New York State Department of Health (NYSDOH) for the 2013 – 2014 influenza season.
Typically, vaccination rates for health care workers are around 60 percent, according to the U.S. Centers for Disease Control and Prevention. The Health System’s overall compliance rate was 82 percent at the start of April.
In a groundbreaking, multi-centered randomized trial published in The New England Journal of Medicine, researchers, co-led by Mount Sinai’s David H. Adams, MD, determined that a catheter-based heart procedure to replace an aortic valve was superior to surgery for patients who have symptomatic severe aortic stenosis with increased risks. The findings, based on a clinical trial involving 795 patients treated at 45 institutions across the nation, were simultaneously presented by Dr. Adams at the 63rd Annual Scientific Session of the American College of Cardiology on Saturday, March 29, and represent a major advance for heart patients who are at high risk for surgery.